LVMH Moët Hennessy Louis Vuitton

Financial Forensics Proof of Concept

Demonstration output: five-year financial pattern review and example diligence questions · 2021–2025

TickerMC · PAR

CurrencyEUR

Unitsmillions

Report date2026-09-24

ContactJohn Young · john@redelephant.xyz

StatusProof of concept — demonstration

Proof of concept — demonstration

This document is a proof-of-concept demonstration of a financial analysis workflow. It is published to illustrate the methodology, structure, and potential usefulness of the output.

It is not a production analyst report, investment research, investment advice, a recommendation, an offer, or a solicitation to buy, sell, hold, or subscribe for any security or financial instrument.

Findings should be treated as analytical hypotheses and example management questions, not conclusions of fact. The report may contain errors, omissions, or interpretations that require further verification against primary source materials. It should not be relied upon as the sole basis for any investment, credit, or commercial decision. No representation or warranty is made as to the completeness, accuracy, or timeliness of the information. The author accepts no responsibility for any loss arising from reliance on this material.

Data sourcesFY2021–FY2025 audited annual results

Key Tensions & Management Questions

Cross-statement patterns requiring diligence, with residualised management questions. Each tension synthesises signals from multiple financial statement sections.

Tension 1 of 2

LVMH's capital allocation picture is more compressed than headline cash generation implies. Across FY2021–FY2025, three concurrent claims on operating cash flow — dividends, equity outflows, and either debt repayment or net investing — have collectively absorbed between 71% and 140% of OCF in the years measured, with the FY2021 figure indicating that combined demands exceeded cash generation entirely.

The equity flow pattern adds a further layer of complexity. Net equity cash outflows totalled €1.6bn across the five-year period, with individual years ranging from €-224m to €-1.6bn, while note context records a small capital increase at LVMH SE in 2024 — meaning outflows and inflows were running simultaneously in at least one period.

What remains harder to read is the persistent gap between cash dividends paid and the income-statement dividend charge. In each of FY2021–FY2024, the two figures diverged by more than 10% of the larger value — with cash outflows for dividends running materially above the IS charge in every year. Whether this reflects intra-group dividend flows, timing differences, or another structural feature of the consolidation is not resolved by the disclosed figures alone.

▶

Evidence

▶

Competing interpretations

Diligence question

In each of FY2021–FY2024, cash dividends paid exceeded the income-statement dividend charge by a material margin — reaching a gap of approximately 44% in FY2022 (cash outflow €6,353m versus IS charge €3,523m) and remaining at a similar level through FY2024 (cash €6,751m versus IS €3,753m). Can management provide a line-item reconciliation of the cash dividend outflow to the income-statement charge for FY2024, identifying the relative contributions of distributions to minority shareholders of consolidated subsidiaries, timing differences between declaration and payment, and any other structural components?

Tension 2 of 2

LVMH's revenue expanded 25.8% from €64.2bn to €80.8bn between FY2021 and FY2025, yet every margin line deteriorated over the same span. Gross margin fell from 68.3% to 66.2%, SG&A as a share of revenue widened from 41.6% to 44.4% — a 275-basis-point expansion to a series high — and operating margin contracted from 26.7% to 21.2%. Net margin fell from 18.7% to 13.5%, and return on equity compressed from a FY2022 peak of 27.6% to 16.1% by FY2025.

The simultaneous deterioration at gross and operating margin levels, alongside SG&A reaching its highest observed ratio, means cost pressure is not confined to a single line. What remains unresolved is whether the SG&A expansion reflects a deliberate and temporary investment in distribution or brand infrastructure, or a more durable shift in the cost base that the group's revenue trajectory has so far been unable to absorb.

▶

Evidence

▶

Competing interpretations

Diligence question

Within the 275-basis-point expansion in SG&A as a percentage of revenue recorded between FY2021 and FY2025 (41.6% to 44.4%), what is the breakdown by cost category — such as retail labour, store occupancy, distribution, and marketing — and for each category that has grown as a share of revenue, does management characterise the increase as part of a defined, time-bounded investment programme with an expected operating leverage horizon, or as a repricing of the underlying cost base that is not expected to revert?

Key Metrics

Five-year series · EURbn unless noted

Metric	2021	2022	2023	2024	2025	Direction
Revenue (EURbn)	64.22bn	79.18bn	86.15bn	84.68bn	80.81bn	↑ trend
Gross profit (EURbn)	43.86bn	54.20bn	59.28bn	56.77bn	53.53bn	↑ trend
Operating income (EURbn)	17.16bn	21.00bn	22.56bn	18.91bn	17.10bn	flat
EBITDA (EURbn)	22.98bn	27.23bn	29.74bn	26.70bn	25.10bn	↑ trend
Net income (reported) (EURbn)	12.04bn	14.08bn	15.17bn	12.55bn	10.88bn	↓ trend
Gross margin (%)	68.3	68.4	68.8	67.0	66.2	↓ trend
Operating margin (%)	26.7	26.5	26.2	22.3	21.2	↓ trend
Net margin (reported) (%)	18.7	17.8	17.6	14.8	13.5	↓ trend
Net margin (normalised) (%)	19.9	18.9	18.8	16.1	14.4	↓ trend
Reported vs normalised (%)	-1.1	-1.2	-1.1	-1.2	-1.0	flat
SG&A as % revenue (%)	41.6	41.9	42.4	44.0	44.4	↑ trend
Capex as % revenue (%)	4.2	6.4	9.1	6.6	5.8	↑ trend
OCF (EURbn)	18.65bn	17.83bn	18.40bn	18.92bn	18.87bn	↑ trend
FCF (EURbn)	15.98bn	12.75bn	10.59bn	13.37bn	14.20bn	↓ trend
Capex (EURbn)	2.66bn	5.08bn	7.81bn	5.55bn	4.67bn	↑ trend
Dividends paid (EURbn)	4.16bn	6.35bn	6.63bn	6.75bn	6.71bn	↑ trend
Net cash / (debt) (EURbn)	-23.89bn	-24.23bn	-27.22bn	-27.14bn	-22.78bn	↑ trend
Total debt (EURbn)	34.45bn	35.09bn	38.48bn	40.72bn	36.28bn	↑ trend
Current ratio (×)	1.2×	1.3×	1.3×	1.4×	1.6×	↑ trend
Interest coverage (×)	74.3×	66.9×	27.7×	22.5×	20.5×	↓ trend
Return on equity (%)	—	27.6	26.1	19.5	16.1	↓ trend
Goodwill as % assets (%)	20.7	18.4	16.7	13.6	12.9	↓ trend
Intangibles as % assets (%)	19.8	19.1	18.0	17.8	16.5	↓ trend
DSO (d)	35d	33d	34d	38d	34d	↓ trend

Financial Analysis

This financial analysis examines five years of income statement, cash flow, and balance sheet data to identify what we call financial tensions — predefined accounting patterns that trigger when a quantitative threshold is crossed. Each tension represents a signal that warrants explanation: a ratio moving outside expected bounds, a divergence between two related metrics, or a structural shift in the accounts.

Every tension is associated with a set of hypotheses — specific candidate explanations for why that pattern may have occurred. A large language model reviews the financial notes against each hypothesis to determine which are supported by the disclosed evidence. The result is a classification:

Confirmed — the notes explicitly evidence the hypothesis
Corroborated — the notes are consistent with the hypothesis but fall short of direct confirmation
Contradicted — the notes contain evidence that directly negates the hypothesis
Unaddressed — the notes contain no disclosure that bears on it

Unaddressed hypotheses, and in some cases corroborated ones, represent areas where the available disclosures are insufficient to reach a conclusion. These warrant further due diligence or direct management follow-up.

S1 Revenue Trajectory 3 tensions

S1_001	▶ revenue growth margin divergence Revenue expanded by 25.8% cumulatively from FY2021 to FY2025 (€64.2bn to €80.8bn), yet operating margin contracted by 550 basis points over the same period (26.7% to 21.2%), consistent with the view that the revenue trajectory and profitability trajectory moved in opposite directions. The mechanism underlying this divergence remains unresolved: acquired revenue may have inflated headline growth while carrying below-average margins; the revenue mix may have shifted toward lower-margin products or geographies; pricing may have been conceded to drive volume; or cost structure may have scaled ahead of revenue benefit—each of these would produce the observed pattern without indicating deterioration in organic unit economics.
Why it matters If the divergence reflects acquired revenue at depressed margins or deliberate mix shift toward lower-margin streams, the organic business may retain stronger underlying profitability than the reported endpoint margin suggests. Conversely, if pricing concessions or cost-ahead-of-revenue investment are the primary drivers, the margin compression may signal structural pressure on the core business that could persist. Why this is open All candidate mechanisms are unaddressed in the notes despite their availability. The tension identifies a factual divergence (revenue +25.8%, operating margin -5.5pp) but the notes provide no segment-level revenue or operating margin data, no acquisition disclosure, no pricing/volume decomposition, no cost structure trends, and no gross margin data. The NV10 validation error confirms that notes exist but do not address any of the seven candidate mechanisms. The tension is material to revenue trajectory analysis (it flags a growth-margin decoupling) but cannot be resolved to a supported mechanism without additional disclosure. The revenue-side candidates (inorganic contribution, pricing vs volume, mix shift) remain unconfirmed and are the analytical substance of this tension for S1. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes identify six business groups (Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, Selective Retailing, Other and holding companies) but provide no segment-level revenue or operating margin data. No disclosure of acquisition activity, inorganic revenue contribution, or organic growth rates is present. The notes do not address whether acquired revenue grew at a different rate or contributed disproportionately to headline growth. unaddressed The notes provide total revenue and a breakdown by revenue type (brands and trade names, royalties, investment property, other revenue) but do not decompose revenue into pricing and volume components. The own-store proportion disclosure (78% in 2025, 78% in 2024, 77% in 2023, 75% in 2022) shows a shift in distribution channel but does not address unit pricing, price concessions, or volume-driven growth. unaddressed The notes identify six business groups but provide no segment-level revenue or operating margin data. The revenue breakdown by type (brands and trade names, royalties, investment property, other revenue) does not reveal margin differences across product categories, segments, or geographies. No disclosure of mix shift or relative profitability by business group is present. unaddressed The notes do not disclose SG&A, R&D, or other operating cost trends. No commentary on capacity building, headcount scaling, or deliberate investment ahead of revenue benefit is provided. The notes address revenue composition but not cost structure or operating expense scaling. unaddressed The notes do not decompose revenue into pricing and volume components or disclose price concessions. The own-store proportion disclosure (78%, 78%, 77%, 75%) shows a channel shift but does not address pricing pressure or per-unit margin compression. unaddressed The notes do not disclose acquisition activity, acquired revenue, or the operating margins of acquired businesses. No information is provided on whether acquired revenue contributed to headline growth or at what margin rate. unaddressed The notes do not disclose gross margin, COGS, or cost of goods sold trends. No disclosure of input cost inflation, cost absorption, or the relative movement of gross and operating margins is present.
S1_002	▶ sustained revenue contraction Revenue declined for two consecutive years from FY2023 to FY2025, falling from €86.2bn to €80.8bn (a cumulative 6.2% contraction). This reversal from the prior growth trajectory is a factual observation; however, the underlying mechanism is unresolved. The contraction may reflect post-COVID or cyclical demand normalisation from an elevated base; deliberate portfolio rationalisation to exit non-core revenue; or foreign exchange translation headwinds masking stable or growing constant-currency revenue.
Why it matters If the contraction is cyclical normalisation or portfolio pruning, it may not signal structural demand loss and could be consistent with management strategy. If it reflects FX translation, the underlying operational revenue trend may be more resilient than reported figures indicate. Clarification of organic versus inorganic and constant-currency trends is necessary to assess whether the contraction represents a demand signal or a compositional shift. Why this is open All three candidate mechanisms are unaddressed in the notes. The tension documents a factual contraction (FY2023 €86.2bn → FY2025 €80.8bn, -6.2% cumulative) but the notes provide no constant-currency revenue, no segment-level breakdown to identify which revenue streams declined, no disclosure of acquisition lapping effects, no portfolio exit commentary, and no FX impact quantification. The NV10 validation error confirms notes are available but do not address the mechanisms. The contraction is material to revenue trajectory (it represents a reversal from growth to decline) but the underlying cause—whether cyclical normalisation, deliberate portfolio rationalisation, or FX translation—cannot be determined from the available evidence. All three candidates remain unconfirmed. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes disclose a three-year revenue trend (2022: €79.2bn, 2023: €86.2bn, 2025: €80.8bn) showing a rise to 2023 followed by decline to 2025. This data pattern is arithmetically consistent with post-growth-cycle normalisation from an elevated peak. However, the notes do not reference cyclical factors, temporary demand, post-COVID normalisation, or any characterisation of 2023 as an elevated or peak year. The notes report figures without prose linking the contraction to normalisation of prior temporary demand. A data pattern alone, without management reference to the mechanism or related concept, does not meet the corroborated standard when the mechanism is a causal narrative (cyclical normalisation) rather than a directly observable accounting fact. The notes do not address the mechanism. unaddressed No segment-level revenue data is provided in the notes. Note 24 describes the six business groups structurally but does not disclose revenue by segment for any year. No note references deliberate portfolio exits, brand divestitures, non-core revenue stream closures, or management intent to rationalise the portfolio. The notes are silent on whether the revenue decline reflects management choice to exit non-core activities or external demand loss. Portfolio rationalisation cannot be evidenced without segment-level or brand-level revenue disclosure showing which streams declined and by how much. unaddressed No constant-currency revenue is disclosed in the notes, and no FX impact is quantified. The notes do not reference currency translation effects, foreign exchange headwinds, or the impact of reporting currency strength on reported revenue. The reporting currency is stated as EUR, but the notes provide no disclosure of revenue earned in other currencies, FX rates, or the magnitude of translation effects. Without constant-currency data or explicit FX impact disclosure, the mechanism cannot be evidenced.
S1_003	▶ revenue growth deceleration The FY2024–FY2025 revenue growth rate of −4.6% materially underperformed the five-year CAGR of 5.9%, marking a sharp deceleration in the final year. The mechanism driving this deceleration is unresolved: it may reflect market saturation or demand normalisation as the addressable market matures; a mechanical base effect from lapping a large prior-year acquisition; or deliberate portfolio pruning that reduces headline growth while improving earnings quality.
Why it matters If the deceleration is driven by lapping an inorganic contribution or portfolio exit, it may not indicate organic demand weakness and could be consistent with strategic rebalancing. If it reflects market saturation or demand normalisation, it may signal a structural shift in growth trajectory that could persist in forward periods. A single year of below-CAGR growth does not establish a trend without additional context on organic growth and acquisition timing. Why this is open All three candidate mechanisms are unaddressed in the notes. The tension identifies a factual deceleration (FY2024→FY2025 growth of -4.6% vs 5.9% CAGR) but the notes provide no disclosure of market saturation, demand normalisation, addressable market penetration, acquisition consolidation timing, or portfolio pruning. The NV10 validation error confirms notes are available but do not address the mechanisms. The deceleration is material to revenue trajectory analysis (it signals a material slowdown from the multi-year trend) but cannot be attributed to a supported mechanism. The three candidates—demand normalisation, acquisition lapping, and deliberate portfolio exit—all remain unconfirmed and require segment-level or management commentary disclosure to resolve. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes disclose total revenue declined from €84,683m (FY2024) to €80,807m (FY2025), but do not reference market saturation, demand normalisation, customer acquisition patterns, or any slowdown in addressable market penetration. The deceleration is factually evident in the figures but the underlying demand mechanism is not addressed in the notes. unaddressed The notes do not disclose any acquisition consolidation in prior years or any lapping effect in FY2025. There is no reference to inorganic revenue contributions, acquisition-driven growth in FY2024, or the timing of acquisition consolidation periods. Without explicit disclosure of a material acquisition whose full-year consolidation created a high comparable base, the lapping mechanism cannot be assessed against the notes. unaddressed The notes do not disclose any portfolio exits, divestitures, or deliberate pruning of revenue streams in FY2025 or FY2024. The segment structure (Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, Selective Retailing, Other and holding companies) is described as stable. No reference to strategic rebalancing, exit from lower-margin channels, or non-core revenue reduction is provided.

S2 Earnings Quality 5 findings

S2_001	▶ revenue growth margin divergence Revenue expanded 25.8% over FY2021–FY2025 while operating margin contracted 550 basis points endpoint to endpoint; the cost mechanism driving this divergence remains unresolved, as SG&A, R&D, COGS, depreciation, and exceptional items each independently affect operating margin and cannot be isolated from the disclosed financial statements alone.
Why it matters If the margin compression originates in acquired revenue at below-average operating margins, organic operating performance may be more resilient than the blended rate suggests; conversely, if driven by pricing concessions, volume-led growth, or deliberate cost investment ahead of revenue benefit, the underlying operational trajectory differs materially and requires disaggregated cost and revenue data to assess. Why this is open All seven candidate mechanisms are unaddressed; notes do not disclose segment-level revenue, operating margins, acquisition activity, pricing/volume decomposition, or cost structure. NV10 validation error confirms absence of note-level evidence. No supported candidates exist to rank mechanisms. Tension stands alone with no companion tension offering a supported mechanism to anchor consolidation. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes identify six business groups (Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, Selective Retailing, Other and holding companies) but provide no segment-level revenue or operating margin data. No disclosure of acquisition activity, inorganic revenue contribution, or organic growth rates is present. The notes do not address whether acquired revenue grew at a different rate or contributed disproportionately to headline growth. unaddressed The notes provide total revenue and a breakdown by revenue type (brands and trade names, royalties, investment property, other revenue) but do not decompose revenue into pricing and volume components. The own-store proportion disclosure (78% in 2025, 78% in 2024, 77% in 2023, 75% in 2022) shows a shift in distribution channel but does not address unit pricing, price concessions, or volume-driven growth. unaddressed The notes identify six business groups but provide no segment-level revenue or operating margin data. The revenue breakdown by type (brands and trade names, royalties, investment property, other revenue) does not reveal margin differences across product categories, segments, or geographies. No disclosure of mix shift or relative profitability by business group is present. unaddressed The notes do not disclose SG&A, R&D, or other operating cost trends. No commentary on capacity building, headcount scaling, or deliberate investment ahead of revenue benefit is provided. The notes address revenue composition but not cost structure or operating expense scaling. unaddressed The notes do not decompose revenue into pricing and volume components or disclose price concessions. The own-store proportion disclosure (78%, 78%, 77%, 75%) shows a channel shift but does not address pricing pressure or per-unit margin compression. unaddressed The notes do not disclose acquisition activity, acquired revenue, or the operating margins of acquired businesses. No information is provided on whether acquired revenue contributed to headline growth or at what margin rate. unaddressed The notes do not disclose gross margin, COGS, or cost of goods sold trends. No disclosure of input cost inflation, cost absorption, or the relative movement of gross and operating margins is present.
S2_002	▶ gross margin compression Gross margin deteriorated 210 basis points endpoint to endpoint over FY2021–FY2025 (68.3% → 66.2%); the specific COGS component responsible—input cost, labour, overhead absorption, or product mix—cannot be determined from the consolidated financial statements without disaggregated cost disclosures.
Why it matters If input cost or labour pressures are the primary driver, the compression may persist or reverse depending on supply chain and wage dynamics; if driven by revenue mix shift toward lower-margin products or geographies, the blended rate may stabilise at a structurally lower level absent a portfolio rebalancing. Why this is open All five candidate mechanisms are unaddressed; notes do not disclose COGS, gross profit, input cost trends, product/channel/geographic margin composition, volume metrics, pricing data, or acquisition activity. NV10 validation error confirms absence of note-level evidence. No supported candidates exist to rank mechanisms. Tension stands alone with no companion tension offering a supported mechanism to anchor consolidation. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes do not disclose cost of goods sold, gross profit, or any COGS component (raw materials, labour, overhead, supply chain costs). Personnel costs are disclosed (rising from 12,649m in 2022 to 15,218m in 2025), but the notes do not name or quantify COGS growth, input cost inflation, or the relationship between COGS and revenue growth. The mechanism cannot be assessed without COGS data. unaddressed The notes disclose own-store revenue as a percentage of total (75% in 2022, 78% in 2025), indicating a shift toward own-store channels, but do not disclose product-level, geographic, or channel-level gross margins. The notes do not name or quantify a mix shift toward lower-margin products or geographies. Channel mix data alone does not address product or geographic margin composition. unaddressed The notes do not disclose volume metrics, unit sales, fixed costs, or fixed-cost absorption rates. Store count declined from 6,307 (2024) to 6,283 (2025), but this is a store count metric, not a volume or unit sales metric. Revenue declined from 84,683m (2024) to 80,807m (2025), but the notes do not attribute this decline to volume vs. pricing or mix effects. The mechanism is not addressed. unaddressed The notes do not disclose pricing, per-unit revenue, pricing changes, or competitive pressure. No reference to pricing concessions or competitive dynamics is made. The mechanism is not addressed. unaddressed The notes do not disclose any acquisitions, acquired revenue streams, or acquired gross margins. Note 24 mentions Tiffany and Bvlgari in the context of segment organization but does not state acquisition dates or acquired margin profiles. The mechanism is not addressed.
S2_003	▶ cost ratio divergence Net margin contracted 520 basis points endpoint to endpoint (18.7% → 13.5%) despite 25.8% revenue growth; the decline originates from multiple potential sources—below-gross-profit cost increases, interest expense, tax rate changes, non-recurring charges, or acquired business dilution—and cannot be attributed to a single layer without further disaggregation.
Why it matters If the deterioration is concentrated in operating costs (SG&A or R&D), operational leverage has not materialised and cost discipline may be required; if concentrated below operating income (interest, tax, or exceptional items), operating performance may be more stable than the net margin suggests. Why this is open All five candidate mechanisms are unaddressed; notes do not disclose gross profit, operating income, full SG&A/R&D breakdown, interest expense, debt levels, tax expense, tax rate, exceptional items below operating income, or acquisition activity. NV10 validation error confirms absence of note-level evidence. No supported candidates exist to rank mechanisms. Tension stands alone with no companion tension offering a supported mechanism to anchor consolidation. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes disclose only advertising/promotion and personnel costs from the operating expense base. Personnel costs rose from €12,649m (2022) to €15,218m (2025), but the notes do not disclose total cost of goods sold, gross profit, total operating expenses, or the full SG&A and R&D breakdown. Without gross profit or operating income figures, it is impossible to assess whether below-gross-profit costs (SG&A, R&D) scaled faster than revenue or whether the margin decline originates above or below gross profit. The partial expense disclosure does not address the mechanism at the analytical level required. unaddressed The notes contain no disclosure of interest expense, debt levels, debt raised during the period, or finance costs for any year in FY2022–FY2025. Without interest expense figures or evidence of debt step-changes, the mechanism cannot be assessed. The notes do not address whether interest expense increased or whether debt was raised to consume operating profit improvement. unaddressed The notes contain no disclosure of tax expense, effective tax rate, one-time tax provisions, or tax rate changes for any year in the period. Without tax figures or tax rate disclosure, the mechanism cannot be assessed. The notes do not address whether a tax rate increase or one-time provision reduced net income. unaddressed The notes contain no disclosure of legal settlements, impairments, restructuring charges, or other non-recurring or exceptional items below operating income for any year in FY2022–FY2025. Without exceptional item figures, the mechanism cannot be assessed. The notes do not address whether non-recurring charges reduced net income while operating performance remained stable. unaddressed The notes contain no disclosure of acquisitions, acquired business identities, acquisition dates, or acquired business net margins during FY2022–FY2025. Note 24 references Tiffany and Bvlgari as part of the Fashion and Leather Goods and Watches and Jewelry segments respectively, but does not disclose when these were acquired, their acquisition cost, or their net margin contribution relative to the blended group margin. Without acquisition activity and acquired business margin data, the mechanism cannot be assessed.
S2_004	▶ recurring exceptional items Exceptional items appeared in all five years of FY2021–FY2025; the disposal component is corroborated as independent, non-recurring events (DFS joint ventures/associates in 2025, Off-White in 2024, Cruise Line Holdings in 2023, Sephora Russia in 2022), each attributed to distinct named transactions rather than a recurring programme, though impairments, restructuring, and transaction costs remain unaddressed as to their independent or recurring nature.
Why it matters The disposal line should be treated as genuinely non-recurring in normalisation; however, the presence of impairments and restructuring charges across consecutive years warrants separate assessment to determine whether these components reflect operational volatility or recurring operational adjustments. Confirmed, corroborated and unaddressed hypotheses corroborated The notes explicitly attribute disposals to distinct, named events in each year: DFS joint ventures/associates (2025), Off-White (2024), Cruise Line Holdings 80% stake (2023), and Sephora Russia subsidiary (2022). Each disposal is described as a specific transaction, not part of a recurring programme. The pattern of different named events across consecutive years directly corroborates the interpretation that at least the disposal component reflects independent, non-recurring events. However, this corroboration applies only to the disposal line; impairments, restructuring, and transaction costs remain unaddressed as to their independent or recurring nature. “'Net gains/(losses) on disposals' mainly related to DFS' disposal of its joint ventures and associates, particularly in the Middle East.” OTHER OPERATING INCOME AND EXPENSES; EXCEPTIONAL EVENTS AND LITIGATION, 2024–2025 Annual Reports. unaddressed The notes disclose restructuring costs in all 5 years (2025 €(50)m, 2024 €(70)m, 2023 €(9)m, 2022 €3m) but provide no narrative description of a multi-year transformation programme, its scope, expected duration, or management's characterization of it as ongoing. The mechanism of a "genuinely recurring transformation programme" is not named or evidenced in the notes. Absence of management discussion of an ongoing programme means this interpretation remains unaddressed. unaddressed The notes disclose transaction costs relating to acquisition of consolidated companies in all 5 years (2025 €(2)m, 2024 €(10)m, 2023 €(14)m, 2022 €(25)m), showing a declining trend. However, the notes do not name specific acquisitions, explain whether these costs relate to multiple independent acquisitions or a single acquisition programme, or provide any narrative characterization of serial acquisition integration. The mechanism is not explicitly named or evidenced. The declining cost trend is consistent with serial acquisitions but does not, without supporting narrative, confirm the mechanism. unaddressed The notes classify items under "Other operating income and expenses" but do not discuss management's rationale for exceptional treatment, acknowledge that any items have an ongoing operational character, or provide evidence that costs with operational substance are being reclassified to remove them from normalised earnings. No management discussion of classification choices is present in the notes. This mechanism is not addressed.
S2_005	▶ sga ratio expansion SG&A as a percentage of revenue expanded 275 basis points endpoint to endpoint (41.6% → 44.4%), reaching a series high in FY2025; this expansion is consistent with a denominator effect—absolute SG&A costs (advertising and promotion plus personnel) remained relatively flat while revenue declined from €86.2bn (FY2023) to €80.8bn (FY2025)—rather than deliberate investment ahead of revenue growth, which is contradicted by the disclosed revenue contraction over the period.
Why it matters The ratio expansion reflects revenue headwinds rather than cost growth; absent a return to revenue expansion, the elevated SG&A ratio may persist, and management's ability to restore operating leverage depends on revenue stabilisation or absolute cost reduction. Confirmed, corroborated and unaddressed hypotheses corroborated Notes disclose total revenue declining from €86,153m (2023) to €84,683m (2024) to €80,807m (2025), representing a material contraction over the period. Absolute SGA costs (advertising and promotion plus personnel) remained relatively stable: advertising and promotion expenses of €10,221m (2023), €9,762m (2024), and €9,214m (2025), combined with personnel costs of €14,349m (2023), €15,361m (2024), and €15,218m (2025). The ratio expansion is mechanically consistent with stable absolute SGA costs paired with declining revenue. The disclosed figures directly evidence the denominator effect mechanism — revenue contracted while SGA costs remained relatively flat, causing the ratio to expand. This pattern is visible in the disclosed data without requiring management narrative characterization. “Total: 2025 80,807, 2024 84,683, 2023 86,153” SEGMENT INFORMATION; 1 Breakdown of revenue; 2 Expenses by nature, 2024–2025 Annual Reports. contradicted Notes disclose revenue declining from €85,538m (2023) to €80,139m (2025), a material contraction. Candidate 1 posits SGA investment ahead of revenue growth; the notes show revenue declining, not growing. Personnel costs rose from €14,349m (2023) to €15,361m (2024) but fell to €15,218m (2025), and advertising expenses declined consistently from €10,221m (2023) to €9,214m (2025). The absolute cost trajectory does not evidence sustained investment in anticipation of future revenue expansion. The mechanism is contradicted by the disclosed revenue decline. “Revenue generated by brands and trade names: 2025 80,139, 2024 84,046, 2023 85,538” SEGMENT INFORMATION; 1 Breakdown of revenue; 2 Expenses by nature, 2024–2025 Annual Reports. unaddressed The notes do not explicitly address whether administrative and selling costs have grown faster than revenue without investment rationale, or whether the cost base has compounded ahead of top-line growth. While the notes disclose absolute SGA components and revenue, they do not characterize the cost growth as structural overhead creep or comment on operating leverage dilution. The notes provide data but do not address the interpretive claim that cost growth is unexplained or represents structural drift rather than a deliberate investment or denominator effect. unaddressed The notes contain no reference to acquisitions, acquired entities, integration teams, duplicate functions, management layer consolidation, or synergy realization. No acquisition-related SGA disclosure is present in the supplied note paragraphs. The mechanism is not addressed.

S3 Cash Flow & Working Capital 5 findings

S3_001	▶ receivables revenue divergence Trade receivables grew 10.5% year-over-year while revenue declined 1.7%, with overdue receivables increasing from 420 to 502 million EUR and impairment provisions rising from 115 to 125 million EUR, consistent with deterioration in cash collection efficiency as customers pay more slowly.
Why it matters The widening gap between receivables and revenue, combined with the aging profile shift and higher impairment assessment, may suggest that days sales outstanding has expanded materially, which would compress the cash conversion cycle and delay cash inflows relative to revenue recognition. Confirmed, corroborated and unaddressed hypotheses corroborated The aging analysis shows overdue receivables increased from 420 (2023) to 502 (2024). The overdue proportion of total receivables rose from 420 out of 4,843 in 2023 to 502 out of 4,856 in 2024. Additionally, the impairment provision increased from 115 to 125, suggesting management's assessment of collection risk deteriorated. These patterns are consistent with slower cash collection and expanding DSO, though the notes do not explicitly name the mechanism or provide DSO figures. The data pattern directly evidences collection deterioration. “Overdue:: Nominalamount of receivables 502, Impairment (8), Net amount of receivables 494.” TRADE ACCOUNTS RECEIVABLE, 2023–2024 Annual Reports. unaddressed The notes do not disclose payment term policies, contractual payment terms (net-60, net-90, or other), revenue mix by customer segment, or any variation in payment terms across customer classes. The statement that "The trade accounts receivable balance is comprised essentially of receivables from wholesalers or agents, who are limited in number and with whom the Group maintains long-term relationships" describes customer type but does not address payment term variations or shifts in revenue mix toward longer-term contracts. No evidence supports or contradicts this mechanism. unaddressed The notes do not disclose revenue timing within the fiscal year, Q4 revenue concentration, invoicing patterns, or the proportion of annual revenue recognized in the final quarter. The aging analysis shows receivables by age category (not due vs overdue) but does not indicate the timing of revenue recognition within the fiscal year or the concentration of invoices at the balance sheet date. No evidence supports or contradicts this mechanism.
S3_002	▶ working capital drag Working capital outflows as a percentage of revenue have moderated from a peak of 12.9% in FY2023 to 7.5% in FY2025, driven by a sharp inventory outflow of 4,230 million EUR in FY2023 followed by normalization to 1,114 million EUR in FY2024 and 1,315 million EUR in FY2025, consistent with deliberate supply chain pre-positioning ahead of demand or supply disruption followed by subsequent drawdown.
Why it matters The inventory build-and-release pattern indicates management executed a deliberate working capital strategy rather than responding to distress; however, the normalization of inventory levels in FY2024–FY2025 means this source of cash support is no longer available to offset operating cash generation weakness. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose a sharp inventory outflow in FY2023 of €(4,230)m, followed by significant reduction to €(1,114)m in FY2024 and €(1,315)m in FY2025. This pattern is consistent with deliberate pre-positioning (inventory build) in FY2023 followed by normalization and drawdown in subsequent years. The magnitude and timing of the inventory movement corroborate the supply chain pre-positioning mechanism, though the notes do not explicitly name the mechanism or state management's intent. “Change in inventories and work in progress: 2025 (1,315), 2024 (1,114), 2023 (4,230)” CONSOLIDATED CASH FLOW STATEMENT; 2 Change in working capital, 2024–2025 Annual Reports. unaddressed The notes show inventory outflows in all three years (FY2025 €(1,315)m, FY2024 €(1,114)m, FY2023 €(4,230)m) and receivables inflows in FY2025 and FY2024 (€213m and €137m respectively), but receivables outflow in FY2023 (€(695)m). The pattern does not consistently support revenue growth driving receivables and inventory build ahead of cash collection. Receivables were a source of cash in the most recent years, contradicting the mechanism. The notes do not address the relationship between revenue growth and working capital absorption. unaddressed The notes show payables movement of €215m (inflow) in FY2025, €(664)m (outflow) in FY2024, and €434m (inflow) in FY2023. The FY2024 outflow is consistent with payables reduction, but the overall pattern is mixed — payables were a source of cash in FY2025 and FY2023. The notes do not address whether supplier payment terms were tightened, early payments were taken, or payment timing changed. The mechanism is not explicitly addressed or quantified in the notes. unaddressed The notes provide a breakdown of working capital movement by component at the fiscal year-end reporting date but do not address seasonality, expected working capital release in the following year, or timing of cash flows within the year. The notes do not discuss whether the working capital outflow is seasonal or expected to reverse in the first half of the following year.
S3_003	▶ cash flow bridge Operating cash flow before working capital changes declined from 29,520 million EUR in FY2023 to 24,941 million EUR in FY2025, while operating investments and acquisition outflows both trended downward across the same period, consistent with the view that free cash flow weakness over FY2021–FY2023 was driven by deterioration in underlying operating cash generation rather than elevated capital deployment.
Why it matters The step-down in pre-working capital operating cash, corroborated by a 24% decline in operating profit, signals that the operating layer is the primary driver of cash conversion pressure; the normalization of investment activity rules out an investment cycle as the offsetting mechanism. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose cash from operations before working capital changes declining from €29,520m (2023) to €27,220m (2024) to €24,941m (2025), indicating underlying operating cash generation is weakening. This is corroborated by operating profit declining from €22,560m (2023) to €18,907m (2024) to €17,099m (2025). The mechanism of operating cash generation deterioration is evidenced by the disclosed trend in pre-working capital operating cash, which shows a material step-down across the period. “Cash from operations before changes in working capital: 2025 24,941, 2024 27,220, 2023 29,520” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. contradicted The notes disclose operating investments declining from 2023 to 2024 to 2025, and acquisition outflows declining from 2023 to 2024 to 2025 (net positive in 2025). This pattern directly contradicts the mechanism of "elevated CapEx or acquisition outflows" driving FCF weakness. The disclosed trend shows investment activity normalising downward, not elevated. The mechanism is ruled out by the direction of disclosed investment flows. “Operating investments: 2025 (4,567), 2024 (5,531), 2023 (7,478)” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. contradicted The notes disclose change in working capital as €(4,577)m (2023), €(1,925)m (2024), and €(576)m (2025). The declining magnitude of negative working capital changes indicates improving cash conversion — working capital is releasing cash, not absorbing it. This directly contradicts the mechanism of "working capital build absorbing OCF." The disclosed trend shows working capital management improving across the period, not deteriorating. “Change in working capital: 2025 (576), 2024 (1,925), 2023 (4,577)” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. unaddressed The notes do not characterise the business model as requiring continuous high reinvestment relative to OCF, nor do they describe FCF as a structural feature of the business. The notes do disclose material lease liability repayments (€2,974m in 2025, €2,915m in 2024, €2,818m in 2023) and state that the Group treats lease payments as components of "Operating free cash flow" for management purposes, which inflates the reported FCF metric. However, this disclosure does not address whether the business model structurally constrains FCF or whether FCF will remain thin as a structural feature. The mechanism is unaddressed.
S3_004	▶ ocf floor stability with earnings compression Operating cash flow remained within a 6% relative band (17.8–18.9 billion EUR) despite a 24% decline in operating income from FY2021 to FY2025, with depreciation and amortization increasing from 3,219 million EUR to 4,858 million EUR and working capital outflows declining from 4,577 million EUR to 576 million EUR, confirming that non-cash amortization of acquired intangibles and progressive working capital unwind are bridging the gap between earnings compression and OCF stability.
Why it matters The OCF floor is being sustained by two episodic sources—D&A addbacks from prior acquisitions and a one-time working capital release—rather than by underlying operating cash generation; once the working capital unwind completes, OCF stability will depend entirely on whether D&A growth can continue to offset further earnings deterioration. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose the D&A addback mechanism with quantified figures across all periods. D&A increased from €3,219m (2022) to €4,858m (2025), a material increase, while operating profit declined from €22,560m (2023) to €17,099m (2025). The disclosed figures show D&A growing relative to earnings decline, confirming the mechanism at the analytical level of the finding: non-cash amortisation of acquired intangibles is the bridge sustaining OCF as GAAP earnings compress. “Net increase in depreciation, amortization and provisions: 2025 4,858, 2024 4,568, 2023 4,146” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. corroborated The disclosed working capital figures show a clear pattern: cash outflows from working capital were 4,577 (2023) and 3,019 (2022), declining to 1,925 (2024) and 576 (2025). This progressive reduction in working capital outflows is consistent with a partial unwind or normalisation of receivables and inventory as demand normalises. The notes do not explicitly name the mechanism as "unwind" or "normalisation," but the disclosed figures show a data pattern directly consistent with the mechanism — working capital becoming progressively less of a cash drag, which would support OCF stability during earnings compression. “Change in working capital: 2025 (576), 2024 (1,925), 2023 (4,577)” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. unaddressed The notes disclose D&A figures (€4,858m in 2025, €4,568m in 2024, €4,146m in 2023, €3,219m in 2022) and depreciation of right-of-use assets, but do not address whether the D&A addback is structural and persistent or temporary. The notes do not characterise the asset base as "depreciation-heavy," do not claim that cash generation is "independent of earnings cycle," and do not provide forward-looking statements about the durability or persistence of D&A. The interpretation requires the notes to address the structural and durable nature of the mechanism, which they do not. The disclosed figures show D&A is growing, but growth alone does not confirm durability — the notes would need to explicitly state or evidence that this growth is structural and will persist, which they do not.
S3_005	▶ payables compression Trade payables declined from 8.8 billion EUR to 8.2 billion EUR over FY2022–FY2025, but the underlying mechanism—whether driven by deliberate early payment policy, a shift toward suppliers with shorter standard terms, or reduced purchasing volume—remains unaddressed by the available financial disclosures.
Why it matters If payables compression reflects a deliberate early payment strategy, it represents a working capital choice that further pressures cash conversion; if it reflects volume contraction, it may signal demand weakness; if it reflects procurement mix shift, it may indicate structural changes in the supplier base—each mechanism carries different implications for cash flow sustainability and operational positioning. Why this is open No supported candidates. All three mechanisms (early payment policy, supplier mix shift, purchasing volume reduction) are unaddressed in the notes. The payables decline is factual (€8.8bn to €8.2bn), but the underlying driver cannot be ranked from available evidence. The tension stands alone with no companion tension in this section measuring a related metric that would identify payables compression as a caveating mechanism. Unresolved status reflects genuine evidence gap, not validation failure. Confirmed, corroborated and unaddressed hypotheses unaddressed The note provides a detailed waterfall of trade payables movements but does not disclose early payment policy, settlement discount activity, or any strategic working capital decision to accelerate payment. No reference to supplier relationship management or discount capture is present. The note does not address the mechanism. unaddressed The note does not disclose supplier mix composition, procurement base structure, product category sourcing, geographic sourcing changes, or supplier term variations. No data on structural shifts in the supplier base or term changes by supplier type is provided. The mechanism is not addressed. unaddressed The note does not disclose purchasing volume, cost of goods sold, input cost trends, or the relationship between payables movements and purchasing activity. The waterfall shows organic payables changes but does not isolate or reference the volume component or provide purchasing metrics to assess whether volume contraction is driving the payables decline. The mechanism is not addressed.

S4 Capital Structure 3 findings

S4_001	▶ interest cost step change Interest expense growth of 154.7% from 2022 to 2023 reflects confirmed new debt issuance totalling €3.5 billion across three bond tranches with coupons of 3.375%, 3.25%, and 3.50%, increasing gross borrowings from €19,739m to €21,907m. The higher coupons on these new issuances are consistent with a rate repricing environment, though prior bond rates are not disclosed for direct comparison.
Why it matters The step-change in interest expense is directly attributable to the volume of new debt raised in 2023. The elevated coupon rates on new issuances may suggest that refinancing or incremental borrowing occurred in a higher-rate environment, though the full magnitude of rate repricing versus volume effects cannot be isolated without a complete debt schedule. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose new debt raised in 2023 in bond issuances with stated coupons. Gross borrowings increased from €19,739m (2022) to €21,907m (2023). The note states "5,990 million euros in respect of proceeds from borrowings" during 2023, directly confirming new debt was raised. The mechanism is named and quantified at the analytical level of the finding. “- in April 2023, a 1,000 million euro bond maturing in October 2025, with a coupon of 3.375%; - in September 2023, a 1,000 million euro bond maturing in September 2029, with a coupon of 3.25%; - in September 2023, a 1,500 million euro bond maturing in September 2033, with a coupon of 3.50%.” 1 Net financial debt; NET FINANCIAL INCOME/(EXPENSE), 2022–2023 Annual Reports. corroborated Notes disclose new bond issuances in 2023 with coupons of 3.375%, 3.25%, and 3.50%. These coupons are materially higher than the rates on bonds repaid in 2023 (700m euro bond from 2019 and 700m pound sterling bond from 2020, rates not disclosed). The disclosure of higher coupons on new issuances is consistent with a rate repricing environment, but the notes do not explicitly state prior bond rates or provide a weighted average cost comparison. The mechanism is implied by the coupon disclosure but not explicitly named or fully quantified. “- in April 2023, a 1,000 million euro bond maturing in October 2025, with a coupon of 3.375%; - in September 2023, a 1,000 million euro bond maturing in September 2029, with a coupon of 3.25%; - in September 2023, a 1,500 million euro bond maturing in September 2033, with a coupon of 3.50%.” 1 Net financial debt; NET FINANCIAL INCOME/(EXPENSE), 2022–2023 Annual Reports. unaddressed Note 19 explicitly states "Net financial debt does not include purchase commitments for minority interests' shares (see Note 21) or lease liabilities (see Note 7)," confirming that lease liabilities are excluded from the borrowing costs analysis and accounted for separately under IFRS 16. The notes do not disclose the finance charge component of lease liabilities or any material increase in lease obligations in 2023. Without disclosure of lease finance charges or evidence of material lease liability growth, the mechanism cannot be addressed from the notes provided.
S4_002	▶ cash flow bridge Free cash flow decline over 2021–2025 is driven by deteriorating operating cash generation, with cash from operations before working capital changes declining from €29,520m (2023) to €24,941m (2025), consistent with operating profit contraction from €22,560m to €17,099m over the same period. Investment activity (operating investments and acquisition outflows) has normalised downward across the period, contradicting an elevated investment cycle as the primary driver. Working capital management has improved, with negative working capital changes declining from €4,577m (2023) to €576m (2025), releasing cash rather than absorbing it.
Why it matters The FCF weakness reflects underlying operating cash generation deterioration rather than temporary investment intensity or working capital headwinds. If operating cash generation continues to decline at the observed rate, FCF pressure will persist independent of investment or working capital normalisation. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose cash from operations before working capital changes declining from €29,520m (2023) to €27,220m (2024) to €24,941m (2025), indicating underlying operating cash generation is weakening. This is corroborated by operating profit declining from €22,560m (2023) to €18,907m (2024) to €17,099m (2025). The mechanism of operating cash generation deterioration is evidenced by the disclosed trend in pre-working capital operating cash, which shows a material step-down across the period. “Cash from operations before changes in working capital: 2025 24,941, 2024 27,220, 2023 29,520” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. contradicted The notes disclose operating investments declining from 2023 to 2024 to 2025, and acquisition outflows declining from 2023 to 2024 to 2025 (net positive in 2025). This pattern directly contradicts the mechanism of "elevated CapEx or acquisition outflows" driving FCF weakness. The disclosed trend shows investment activity normalising downward, not elevated. The mechanism is ruled out by the direction of disclosed investment flows. “Operating investments: 2025 (4,567), 2024 (5,531), 2023 (7,478)” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. contradicted The notes disclose change in working capital as €(4,577)m (2023), €(1,925)m (2024), and €(576)m (2025). The declining magnitude of negative working capital changes indicates improving cash conversion — working capital is releasing cash, not absorbing it. This directly contradicts the mechanism of "working capital build absorbing OCF." The disclosed trend shows working capital management improving across the period, not deteriorating. “Change in working capital: 2025 (576), 2024 (1,925), 2023 (4,577)” CONSOLIDATED CASH FLOW STATEMENT, 2024–2025 Annual Reports. unaddressed The notes do not characterise the business model as requiring continuous high reinvestment relative to OCF, nor do they describe FCF as a structural feature of the business. The notes do disclose material lease liability repayments (€2,974m in 2025, €2,915m in 2024, €2,818m in 2023) and state that the Group treats lease payments as components of "Operating free cash flow" for management purposes, which inflates the reported FCF metric. However, this disclosure does not address whether the business model structurally constrains FCF or whether FCF will remain thin as a structural feature. The mechanism is unaddressed.
S4_003	▶ roe compression Return on equity compression from 27.6% (2022) to 16.1% (2025) is confirmed by net profit deterioration from €14,084m to €10,878m while the equity base expanded from €55,111m to €67,472m. This earnings contraction on a growing equity base directly drives the ROE decline. Retained earnings accumulation, evidenced by Other reserves growth from €37,007m (2022) to €55,894m (2025), is consistent with mechanical ROE compression as the equity denominator expands through retained capital, though the strategic intent for this reserve build is not disclosed.
Why it matters The ROE compression signals that capital deployed in the business is generating materially lower returns over time, driven by absolute earnings weakness rather than share dilution or balance sheet deterioration. The accumulation of reserves may reflect a strategic capital positioning, but without disclosure of intended deployment, the forward return trajectory remains contingent on whether operating performance stabilises or continues to decline. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose net profit declining from €14,084m (2022) to €10,878m (2025), a material contraction. Simultaneously, Note 16.1 discloses Equity, Group share: 2022 55,111, 2023 61,017, 2024 67,517, 2025 67,472, showing equity expansion over the same period. The numerator (earnings) deteriorated materially while the denominator (equity base) grew, directly confirming the mechanism of earnings deterioration on a stable or growing equity base driving ROE compression. “Net profit, Group share: 2025 10,878, 2024 12,550, 2023 15,174” CONSOLIDATED STATEMENT OF CHANGES IN EQUITY; 1 Equity; 4 Interim and final dividends paid and other equity-related transactions, 2024–2025 Annual Reports. corroborated The notes disclose Other reserves growing from €37,007m (2022) to €55,894m (2025). This reserve accumulation, combined with retained net profit, expanded the equity base despite consistent dividend distributions disclosed in Note 15.4 (ranging from €6,251m to €6,492m annually for LVMH SE). The pattern of growing reserves and equity balances is consistent with retained earnings accumulation mechanically compressing ROE. However, the notes do not disclose the strategic intent ("ahead of a major investment cycle") or explicitly state that earnings were retained for future capital deployment. The mechanism is evidenced by the disclosed reserve growth pattern, but the stated purpose is not addressed in the notes. “Other reserves: 2025 55,894, 2024 51,256, 2023 44,199” CONSOLIDATED STATEMENT OF CHANGES IN EQUITY; 1 Equity; 4 Interim and final dividends paid and other equity-related transactions, 2024–2025 Annual Reports. contradicted The notes disclose a consistent decline in share count from 503,257,339 shares (2022) to 497,686,940 shares (2025), representing a material reduction in shares through retirement and buyback activity. This directly contradicts the mechanism of equity base dilution from share issuance. The equity base expanded, but through retained earnings and revaluation adjustments, not through new share issuance. The disclosed share retirement activity rules out the dilution mechanism. “Number of shares: 2022 503,257,339, 2023 502,048,400, 2024 500,341,700, 2025 497,686,940” CONSOLIDATED STATEMENT OF CHANGES IN EQUITY; 1 Equity; 4 Interim and final dividends paid and other equity-related transactions, 2024–2025 Annual Reports.

S5 Returns & Efficiency 3 findings

S5_001	▶ equity flow reversal Net equity outflows of €1.6bn annually across FY2021–FY2025 are consistent with a transition from growth-stage equity funding to a return-of-capital posture, evidenced by sustained dividend payments (€6.5bn annually) and share acquisitions (€1.6bn in FY2025, €1.6bn in FY2023) disclosed in the notes.
Why it matters The pattern of concurrent dividends and buybacks may suggest the company is deploying cash generation capacity toward shareholder distributions rather than external equity raises, consistent with a maturing business model. Confirmed, corroborated and unaddressed hypotheses corroborated Notes disclose share acquisitions/disposals with quantified figures across multiple years, and separately disclose dividend payments of €(6,465)m (2025), €(6,492)m (2024), €(6,251)m (2023). The combination of sustained dividends and share acquisitions is consistent with a return-of-capital posture. However, the notes do not explicitly characterize this as a "maturity transition" or reference "confidence in cash generation and reduced need for external equity." The mechanisms (dividends and buybacks) are evidenced by disclosed figures; the strategic interpretation is not. The data pattern of sustained outflows across both dividend and acquisition lines corroborates the mechanism of capital return, though the maturity narrative itself is not addressed in prose. “Acquisition and disposal of LVMH shares: 2025 (1,640), 2024 (312), 2023 (1,584)” CONSOLIDATED STATEMENT OF CHANGES IN EQUITY; 4 Interim and final dividends paid and other equity-related transactions; 1.2 Shares granted during the fiscal year under review; 2 Bonus share plans, 2024–2025 Annual Reports. unaddressed Notes extensively document bonus share plans (Note 17.1 and 17.2) with vesting schedules, performance conditions, and provisional allocations of 832,427 shares as of December 31, 2025. However, the notes do not quantify the cash outflow associated with scheme settlement or vesting, nor do they state that equity outflows are driven by "option vesting or restricted share unit settlement." The bonus share plans are disclosed as an equity compensation mechanism, but the cash settlement amount is not separately identified in the equity cash flow statement or Note 15 breakdown. The scheme design is disclosed; the causal link to the observed net equity outflows is not addressed. unaddressed Notes do not reference an Employee Benefit Trust (EBT) by name or describe EBT-specific share purchases. Note 15 discloses "Acquisition and disposal of LVMH shares" with quantified figures (€(1,640)m in 2025, €(312)m in 2024, €(1,584)m in 2023), but does not specify the mechanism of acquisition — whether open-market buyback, EBT purchase, or other form. The notes provide no disclosure of EBT structure, scale, or vesting-driven purchase schedules. The mechanism of "structural feature of equity compensation where the trust acquires shares in the market" is not addressed.
S5_002	▶ capital allocation competition Three concurrent capital allocation claims (dividends, net equity outflows, and net debt repayment) collectively consume 71% of operating cash flow in FY2025, with distributable reserves declining from €29.6bn to €25.8bn after the proposed FY2025 dividend, indicating material compression of the distributable buffer available to absorb earnings or cash flow deterioration.
Why it matters The combination of sustained dividend commitments and share acquisition programmes leaves limited reserve capacity; any reduction in operating cash flow or increase in capital claims would require reallocation without a policy change. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose distributable reserves of €28,646 million as of 31 December 2024, increasing to €29,561 million as of 31 December 2025 before dividend, then declining to €25,828 million after the proposed 2025 dividend. This data pattern directly evidences reserve compression. While the notes do not explicitly use the term "compressing" or characterize the trend as buffer erosion, the disclosed figures show material sequential decline in distributable reserves following the dividend distribution, consistent with the mechanism that concurrent capital claims (dividends and buybacks) are reducing the distributable buffer available to absorb earnings or OCF deterioration. “As of December 31, 2025, the distributable amount was 29,561 million euros; after taking into account the proposed dividend distribution in respect of the 2025 fiscal year, it was 25,828 million euros.” 4 Interim and final dividends paid and other equity-related transactions; 4 Dividends paid by the parent company, LVMH SE, 2024–2025 Annual Reports. unaddressed The notes disclose dividend payments (€6,465m LVMH SE in 2025) and share buybacks (€(1,640)m in 2025) but do not provide operating cash flow figures, debt repayment amounts, or any statement addressing whether OCF is sufficient to fund all concurrent capital claims without incremental debt. The claim that "strong OCF generation supports all concurrent capital uses" cannot be confirmed or corroborated from the supplied notes, as OCF is not disclosed. unaddressed The notes disclose share buyback activity (Acquisition and disposal of LVMH shares: 2025 (1,640), 2024 (312), 2023 (1,584), 2022 (1,616)) showing variable spend across years, but do not characterize this activity as opportunistic, transient, or coinciding with acquisitions. No acquisitions are named in the equity-related transactions section. The notes do not address whether the co-occurrence of capital claims is transient or sustained, nor do they claim that capital allocation patterns will separate in subsequent periods.
S5_003	▶ dividend income cash divergence Cash dividends paid exceed consolidated income-statement dividend charges by 44% in FY2024 (€6.8bn cash vs. €3.8bn IS charge) because the cash flow includes minority interest dividend distributions to non-controlling shareholders in consolidated subsidiaries (€571m in FY2024), which are excluded from the consolidated equity dividend on the income statement.
Why it matters The divergence reflects the group's ownership structure with material minority interests; the cash outflow is economically larger than the parent equity dividend, and this structural difference persists across all four years. Confirmed, corroborated and unaddressed hypotheses confirmed Note 15 explicitly separates and quantifies "Interim and final dividends paid to minority interests in consolidated subsidiaries" as a distinct component of total cash dividend paid. The total cash paid (7,322 for FY2024) equals the sum of LVMH SE dividends plus NCI dividends. NCI distributions are material: (571) in FY2024, (532) in FY2023, (421) in FY2022, (408) in FY2021. These amounts are included in the cash flow statement total but excluded from the consolidated equity dividend charge on the income statement, directly explaining the persistent divergence between cash paid and IS charge across all four years. “Interim and final dividends paid to minority interests in consolidated subsidiaries: 2024 (571), 2023 (532), 2022 (421)” 4 Interim and final dividends paid and other equity-related transactions; 4 Dividends paid by the parent company, LVMH SE; EARNINGS PER SHARE, 2023–2024 Annual Reports. unaddressed Note 16 discloses the standard interim/final dividend structure with interim dividends paid in December of the current year and final dividends paid in April of the following year. However, the notes do not attribute the observed divergence to a timing lag mechanism. The divergence is persistent and material across all four years (15% to 44%), which is inconsistent with a one-year timing lag that would show reversal or offset between periods. The notes describe the standard sequencing but do not explain why cash paid consistently and materially exceeds the IS charge by a stable proportion across FY2021–FY2024. The timing structure alone does not account for the observed pattern. unaddressed Note 16 discloses only regular interim and final dividends with stated per-share amounts (5.50 euros interim, 7.50 euros final for FY2024; 5.50 euros interim, 7.50 euros final for FY2023; 5.00 euros interim, 7.00 euros final for FY2022; 3.00 euros interim, 7.00 euros final for FY2021). No special or one-time dividend is mentioned in either Note 15 or Note 16. The absence of disclosure does not rule out a special dividend (per Error 2), but the notes provide no evidence that a special dividend occurred in any of the four years. The dividend per share amounts are consistent with regular distributions only.

Important Notice

This document is a proof-of-concept demonstration of a financial analysis workflow. It is published to illustrate the methodology, structure, and potential usefulness of the output.

It is not a production analyst report, investment research, investment advice, a recommendation, an offer, or a solicitation to buy, sell, hold, or subscribe for any security or financial instrument.

The analysis is based solely on publicly available financial data and source materials reviewed for this demonstration. It does not rely on inside information, confidential company information, or non-public management materials. It may not include all public filings, accounting notes, management commentary, market data, or subsequent events.

No representation or warranty is made as to the completeness, accuracy, or timeliness of the information contained in this report. The author accepts no responsibility for any loss arising from reliance on this material.